PGF and preeclampsia: The main finding of this prospective longitudinal study showed that the use of LDA affected the sFlt-1/PlGF ratio in women with a pathologic first trimester screening for preeclampsia in a dose-dependent manner and showed a trend towards an improved sFlt-1/PlGF ratio in women with preeclampsia in a previous pregnancy.